The ClC-7 chloride (Cl−)-proton (H+) antiporter (also known as CLCN7) is localized to the endolysosomal compartments and mutations in CLCN7 lead to osteopetrosis and neurodegeneration. This evidence concerns the gene CLCN7 and osteopetrosis.